AIDS patients face risk for esophageal, stomach cancers

September 24, 2012

People with AIDS are at increased risk for developing esophageal and stomach carcinoma as well as non-Hodgkin lymphomas (NHLs), according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association.

"People diagnosed with AIDS are living longer due to improved therapies. However, they remain at increased risk of developing a number of different cancers," said E. Christina Persson, PhD, of the and lead author of this study. "An elevated risk of esophageal and stomach cancers had been observed before, but we were able to look at risk for subtypes of these malignancies."

In this study, researchers analyzed data from the HIV/AIDS Cancer Match Study, which links data collected from 1980 to 2007 for 16 U.S. population-based HIV and AIDS and cancer registries. They compared risks of stomach and esophageal cancers in 596,955 people with AIDS with those of the general population.

Those with AIDS had a 69 percent and 44 percent increased risk of esophageal and stomach carcinomas, respectively. The risks of NHLs—tumors of —in the stomach and esophagus were also strongly elevated. Additionally, the researchers' analysis showed a significant 53 percent increased risk of cancer of the lower stomach in people with AIDS. Since Helicobacter pylori infection is one of the causes of this type of , one explanation for an increased risk of this cancer might be an increased prevalence of H. pylori in people with AIDS.

Another explanation for this elevated could be more frequent use of tobacco and alcohol among people with AIDS. Programs encouraging and alcohol moderation may help reduce the occurrence of esophageal and stomach carcinomas among these patients.

Explore further: Cancer burden shifts for people with HIV/AIDS

Related Stories

Cancer burden shifts for people with HIV/AIDS

April 11, 2011
The number of cancers and the types of cancers among people living with AIDS in the U.S. have changed dramatically during the 15-year period from 1991-2005, according to an article published online April 11th in the Journal ...

Reduce esophageal cancer danger by knowing risk factors

August 7, 2012
(Medical Xpress) -- As the American obesity epidemic has increased the past two decades, so has the rate of esophageal cancers. Clinician-scientists affiliated with the University of Cincinnati (UC) Cancer Institute say enhanced ...

Recommended for you

Outdoor light at night linked with increased breast cancer risk in women

August 17, 2017
Women who live in areas with higher levels of outdoor light at night may be at higher risk for breast cancer than those living in areas with lower levels, according to a large long-term study from Harvard T.H. Chan School ...

Scientists develop novel immunotherapy technology for prostate cancer

August 17, 2017
A study led by scientists at The Wistar Institute describes a novel immunotherapeutic strategy for the treatment of cancer based on the use of synthetic DNA to directly encode protective antibodies against a cancer specific ...

Scientists develop blood test that spots tumor-derived DNA in people with early-stage cancers

August 16, 2017
In a bid to detect cancers early and in a noninvasive way, scientists at the Johns Hopkins Kimmel Cancer Center report they have developed a test that spots tiny amounts of cancer-specific DNA in blood and have used it to ...

Toxic formaldehyde is produced inside our own cells, scientists discover

August 16, 2017
New research has revealed that some of the toxin formaldehyde in our bodies does not come from our environment - it is a by-product of an essential reaction inside our own cells. This could provide new targets for developing ...

Cell cycle-blocking drugs can shrink tumors by enlisting immune system in attack on cancer

August 16, 2017
In the brief time that drugs known as CDK4/6 inhibitors have been approved for the treatment of metastatic breast cancer, doctors have made a startling observation: in certain patients, the drugs—designed to halt cancer ...

Researchers find 'switch' that turns on immune cells' tumor-killing ability

August 16, 2017
Molecular biologists led by Leonid Pobezinsky and his wife and research collaborator Elena Pobezinskaya at the University of Massachusetts Amherst have published results that for the first time show how a microRNA molecule ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.